anticancer therapeutics (Sopherion)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanticancer therapeutics (Sopherion)
Drug Alias NameST-100006ST-100059ANG-6ST-100057
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMetastasis inhibitorsAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasm MetastasisLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSopherion Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSopherion Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A